(Q34582722)

English

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

Désirée van der Heijde

10

object named as

Désirée van der Heijde

0 references

4

object named as

Henry Krum

1 reference

Europe PubMed Central

3 August 2017

Claire Bombardier

8

object named as

Claire Bombardier

1 reference

Europe PubMed Central

3 August 2017

author name string

Christopher P Cannon

1

1 reference

Europe PubMed Central

3 August 2017

Sean P Curtis

2

1 reference

Europe PubMed Central

3 August 2017

Garret A FitzGerald

3

1 reference

Europe PubMed Central

3 August 2017

Amarjot Kaur

5

1 reference

Europe PubMed Central

3 August 2017

James A Bolognese

6

1 reference

Europe PubMed Central

3 August 2017

Alise S Reicin

7

1 reference

Europe PubMed Central

3 August 2017

Michael E Weinblatt

9

1 reference

Europe PubMed Central

3 August 2017

Erland Erdmann

11

1 reference

Europe PubMed Central

3 August 2017

Loren Laine

12

1 reference

Europe PubMed Central

3 August 2017

MEDAL Steering Committee

13

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

1 November 2006

1 reference

Europe PubMed Central

3 August 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

3 August 2017

368

1 reference

Europe PubMed Central

3 August 2017

1771-1781

1 reference

Europe PubMed Central

3 August 2017

9549

1 reference

Europe PubMed Central

3 August 2017

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib for the prevention of sporadic colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Raising the safety bar--the FDA's coxib meeting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of cardiovascular complications of diabetes mellitus by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the management of rheumatoid arthritis: 2002 Update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The COX-2 inhibitors--an update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Group sequential designs using a family of type I error probability spending functions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of etoricoxib, a novel, selective COX-2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of prostacyclin in the cardiovascular response to thromboxane A2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(06)69666-9

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34582722&oldid=1948523709"